ALCOHOL DRINKING IN RATS IS ATTENUATED BY THE MIXED 5-HT1 AGONIST 5-HT2 ANTAGONIST FG 5893

被引:25
|
作者
SINGH, GK
KALMUS, GW
BJORK, AK
MYERS, RD
机构
[1] E CAROLINA UNIV,SCH MED,DEPT PHARMACOL,GREENVILLE,NC 27858
[2] E CAROLINA UNIV,SCH MED,DEPT PSYCHIAT MED,GREENVILLE,NC 27858
[3] E CAROLINA UNIV,DEPT BIOL,GREENVILLE,NC 27858
[4] KABI PHARMACIA AB,BUSINESS UNIT CNS,MALMO,SWEDEN
关键词
ALCOHOL DRINKING; SEROTONIN; BRAIN; ETHANOL INTAKE; ALCOHOL PREFERENCE; DOPAMINERGIC SYSTEMS; MESOLIMBIC SYSTEM; 5-HT2; RECEPTORS; ALCOHOLISM; 5-HT1A RECEPTORS;
D O I
10.1016/0741-8329(93)90043-N
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Over the last three decades, the neurotransmitter serotonin (5-HT) has been implicated in the etiological mechanisms underlying the excessive drinking of ethyl alcohol. Recently, the 5-HT2 antagonist amperozide was found to reduce selectively the high intake of alcohol in the cyanamide-induced drinking rat without any adverse side effects. The purpose of the present study was to determine the action on alcohol drinking of the novel second-generation amperozide-like drug, which is a mixed 5-HT1 agonist/5-HT2 antagonist, FG 5893 (2-[4-[4,4-bis(4-fluorophenyl)butyl]-l-piperazinyl]-3-pyridinecarboxylic acid methyl ester). To induce preference for alcohol in Sprague-Dawley rats, the enzyme aldehyde dehydrogenase was inhibited by cyanamide administered in the absence of alcohol in a dose of 10 mg/kg twice a day over three days. A standard three-bottle preference test was used in which water and a maximally preferred concentration of alcohol were offered to each animal. Following control tests of alcohol preference for 3 days, either a saline control vehicle or FG 5893 in a dose of 0.5, 1.0, or 2.5 mg/kg was administered subcutaneously at 1600 and 2200 for 3 consecutive days. Whereas control injections of saline were without effect on alcohol consumption, all doses of FG 5893 significantly reduced the 24-h intake of alcohol in terms of both absolute g/kg and proportion of alcohol to total fluid intake. Further, the 1.0 and 2.5 mg/kg doses of FG 5893 continued to suppress alcohol consumption over two 4-day tests immediately following the injection sequence and after a 40-day interval. Neither body weights nor intakes of food of the rats were affected by FG 5893 either during or after its administration. Thus, it is proposed that this putative anxiolytic and antidepressant drug causes a prolonged modification in the function of serotonergic synapses in the mesolimbic system of the brain. Because FG 5893 possesses combined 5-HT1A agonist and 5-HT2 antagonist characteristics, it is envisaged that the addictive property of alcohol may in part involve a concurrent perturbation in the function of these two subtypes of scrotonergic receptors.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [41] Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S21357
    Griebel, G
    Blanchard, DC
    Rettori, MC
    GuardiolaLemaitre, B
    Blanchard, RJ
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (02) : 509 - 516
  • [42] Role of 5-HT1A and 5-HT2 receptors of dorsal and median raphe nucleus in tolerance to morphine analgesia in rats
    Nayebi, ARM
    Charkhpour, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (02) : 203 - 207
  • [43] Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats
    Takao, K
    Nagatani, T
    Kitamura, Y
    Yamawaki, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) : 123 - 128
  • [44] The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B
    Laura C. Scarlota
    John A. Harvey
    Vincent J. Aloyo
    Psychopharmacology, 2011, 213 : 393 - 401
  • [45] SEROTONIN 5-HT1 AND 5-HT2 RECEPTORS IN ADULT-RAT BRAIN AFTER NEONATAL DESTRUCTION OF NIGROSTRIATAL DOPAMINE NEURONS - A QUANTITATIVE AUTORADIOGRAPHIC STUDY
    RADJA, F
    DESCARRIES, L
    DEWAR, KM
    READER, TA
    BRAIN RESEARCH, 1993, 606 (02) : 273 - 285
  • [46] SUBCHRONIC TREATMENT WITH ANXIOLYTIC DOSES OF THE 5-HT1A RECEPTOR AGONIST IPSAPIRONE DOES NOT AFFECT 5-HT2 RECEPTOR SENSITIVITY IN THE RAT
    BAUDRIE, V
    DEVRY, J
    BROQUA, P
    SCHMIDT, B
    CHAOULOFF, F
    GLASER, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (03) : 395 - 406
  • [47] Influence of 5-HT2 Receptor Agonist on Cardiac Pumping Function of Trained Offspring of Trained Rats
    Valeev, A. M.
    Abzalov, N. I.
    Abzalov, R. A.
    Nigmatullina, R. R.
    Abzalov, R. R.
    Nikitin, A. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (03) : 315 - 318
  • [48] A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans
    Yatham, LN
    Steiner, M
    Liddle, PF
    Shiah, IS
    Lam, RW
    Zis, AP
    Coote, M
    PSYCHOPHARMACOLOGY, 2000, 151 (04) : 424 - 427
  • [49] THE RELATION OF CENTRAL 5-HT1A AND 5-HT2 RECEPTORS - LOW-DOSE AGONIST-INDUCED SELECTIVE TOLERANCE IN THE RAT
    PRANZATELLI, MR
    PLUCHINO, RS
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (02) : 407 - 413
  • [50] Molecular and functional characterization of proteins interacting with the C-terminal domains of 5-HT2 receptors:: Emergence of 5-HT2 "Receptosomes"
    Gavarini, S
    Bécamel, C
    Chanrion, B
    Bockaert, J
    Marin, P
    BIOLOGY OF THE CELL, 2004, 96 (05) : 373 - 381